Aug 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2020 Jun 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.33 15.11 61.00
(-11.8 pct) (-1.0 pct) (+0.9 pct)
Operating 1.06 1.33 4.30
(-20.3 pct) (-18.6 pct) (+5.0 pct)
Recurring 634 mln 1.56 3.90
(-59.3 pct) (-10.6 pct) (+0.5 pct)
Net 974 mln 1.15 3.30
(-15.0 pct) (-48.9 pct) (+12.8 pct)
EPS 21.05 yen 24.14 yen 71.47 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T